Painkiller maker Oxford Cannabinoid Technologies debuts on London’s market May 21, 2021 Oxford Cannabinoid Technologies (OCT), which makes painkillers using cannabis components, has debuted on the London Stock Exchange this morning, offering £0.01 per share. The UK-based company, a pre-revenue pharmaceutical company developing cannabinoid-based prescription medicines, will begin trading on the capital’s main market at 8:00 this morning. Offering around 960m ordinary shares, OCT is set to [...]
Snoop Dogg-backed company making painkillers from cannabis to list in London May 18, 2021 A pharmaceutical company that develops cannabinoid-based prescription medicine and is backed by Snoop Dogg will list on London’s main market later this week. The listing is expected to take place on Friday 21 and will value the company at around £48m. The public offering has been heavily oversubscribed. Oxford Cannabinoid Technologies (OCT) aims to develop [...]
Exclusive: Medical cannabis company chaired by former Lord Mayor of London to float on LSE May 12, 2021 Hellenic Dynamics, a medical cannabis cultivation business, plans to list on the London Stock Exchange next month, in a move likely to give the budding business a valuation of £50m. The group will list on the main market of the London Stock Exchange via reverse takeover into a shell company. “What we were looking for [...]
Exclusive: EU’s biggest hemp producer sees profits grow 616 per cent in 2020 May 3, 2021 HempFlax saw its profits before tax skyrocket 616 per cent in 2020 to €659,000, as demand grew for its construction materials and CBD. The EU’s biggest hemp grower, headquartered in Holland, saw full year revenues up 43 per cent to €14.5m in 2020, with EBITDA increasing 63 per cent to €1.8m. The numbers were in [...]
Back of the net: Beckham-backed cannabis company scores soaring market debut February 26, 2021 UK-based Cellular Goods, a cannabis company backed by David Beckham, has seen its stock price soar on its first day trading on the London Stock Exchange (LSE). The company’s share price rocketed 310 per cent in early trading, continuing the trend of cannabis-related companies listing on the stock market in the UK and then soaring [...]
Exclusive: Purity Hemp CEO on the UK’s fast-growing medical cannabis market February 24, 2021 After losing his sister to cancer and his best man to an opioid addiction, Canada-born, London-based Michael Walker felt he should explore alternative healthcare options so not to rely on Big Pharma. The former head of marketing at Heathrow Express left the advertising industry in 2016 to set up his own company, the Purity Wellness [...]
Will London’s budding cannabis market turn the EU green with envy? February 18, 2021 One after the other, medical cannabis companies are listing on the London Stock Exchange (LSE), and investors are piling in cash, keen to be early investors in what they hope will become a major industry in the UK. It is an exciting time for the medicinal cannabis industry. In September, City regulator the Financial Conduct [...]
Cannabis rally goes up in smoke as shares plummet February 11, 2021 Cannabis stocks gave up its earlier highs on Thursday afternoon with leading US firms plummeting between 20 and 40 per cent. Cannabis stocks were among the most traded by German retail investors this morning, as a buying frenzy that has lit up the sector intensified. Tilray was the most traded stock on German trading platform [...]
Medical cannabis firm MGC Pharmaceuticals to float on LSE February 9, 2021 Medicinal cannabis firm MGC Pharmaceuticals has announced plans to float on the main market of the London Stock Exchange. MGC Pharma is a European-based bio-pharma company specialising in the production and development of phytocannabinoid-derived medicines. As part of the listing process, the company intends to raise gross proceeds of approximately £6.5m via institutional and other [...]
The new Greenback: Why investors are getting high on medicinal cannabis firms February 8, 2021 Avihu Tamir is CEO of Kanabo For years, advocates of medicinal cannabis products have predicted that the industry is set to revolutionise healthcare – and make investors a tidy profit. That time may finally be coming. Take our firm, Kanabo Group, which became the first medicinal cannabis company to get approval from the Financial Conduct [...]